Delta-9-tetrahydrocannabinol ( 9 -THC) is widely established as a modulator of host-immune responses. Accordingly, the objective of the present study was to examine the effects of 9 -THC on the immune response within the lungs and associated changes in the morphology of the bronchiolar epithelium after one challenge with a non-lethal dose of the influenza virus A/PR/8 (PR8). C57BL/6 mice were treated by oral gavage with 9 -THC and/or vehicle (corn oil) for 5 consecutive days. On day three, mice were instilled intranasally with 50 plaque-forming units of PR8 and/or vehicle (saline) four hours prior to 9 -THC exposure. Mice were subsequently killed 7 and 10 days post-infection (dpi). Viral hemagglutinin 1 (H1) mRNA levels in the lungs were increased in a dose-dependent manner with 9 -THC treatment. Enumeration of inflammatory cell types in bronchoalveolar lavage fluid showed an attenuation of macrophages and CD4 + and CD8 + T cells in 9 -THC treated mice when compared with control. Likewise, the magnitude of inflammation and virus-induced mucous cell metaplasia (MCM), as assessed by histopathology, was reduced in 9 -THC treated mice by 10 dpi. Collectively, these results suggest that 9 -THC treatment increased viral load, as assessed by H1 mRNA levels, through a decrease in recruitment of macrophages and lymphocytes, particularly CD4 + and CD8 + T cells, to the lung.
Introduction
Influenza viruses are common human respiratory pathogens throughout the world.
Aerosol droplets released from infected individuals spread influenza virus person-to-person. In immunocompetent human hosts, the virus infects the airway epithelium lining the respiratory tract (Van Reeth, 2000) eliciting an immune response in which both innate and acquired immunity play a critical role in viral clearance. Aside from the lytic activity of the virus alone, infected epithelial cells are also destroyed by the actions of CD8 + cytotoxic T cells (CTL) (Topham et al., 1997) . In addition, there is growing support for the role of CD4 + T cells as contributing immune effectors in the protection against influenza (Brown et al., 2004; Swain et al., 2006) . CD4 + T cells carry out this role through the promotion of longlasting CD8 + T memory cells, mediating the clearance of virus in an IFN-γ-dependent mechanism, by direct cytolytic effects on infected cells via Fas-FasL interactions, or by a combination of these functions . The aforementioned findings illustrate the complex, as well as redundant, mechanisms employed by the immune system to defend the host against infectious pathogens.
Delta-9-tetrahydrocannabinol ( 9 -THC) is the primary psychoactive component in marijuana and is one of more than sixty structurally-related cannabinoids identified in the plant,
Cannabis sativa (Dewey, 1986) . Exposure to 9 -THC occurs either through inhalation as a part of a complex mixture of chemicals including cannabinoids and pyrolysis products of smoked marijuana (e.g., recreational use) or via oral consumption as a synthetically-derived therapeutic for the treatment of such symptoms as AIDS-induced wasting or chemotherapy-induced emesis (e.g., dronabinol). For the latter immunocompromised groups, cancer patients and those suffering from AIDS, there is concern over their use of potentially immunosuppressive cannabinoids.
Cannabinoids, including 9 -THC, are widely established as immunomodulators, affecting innate, JPET #124719 5 humoral, and cell-mediated immune responses in a variety of animal and cell-based models [reviewed by Berdyshev, 2000] . Accordingly, decreased host-resistance to opportunistic pathogens (Morahan et al., 1979; Cabral et al., 1986; Specter et al., 1991; Klein et al., 2000) has rendered 9 -THC exposure as a potential determinant of susceptibility.
The objective of the current study was to evaluate the effect of 9 -THC exposure on the primary immune response to influenza infection (Buchweitz et al., 2007) and affected airways. In particular, we sought to characterize the effects of 9 -THC on the levels of viral H1 expressed in the lung and on immune cell recruitment and soluble chemokines/cytokines in the BALF.
Morphologic changes in the surface epithelium lining the intrapulmonary conducting airway that occur as a consequence of viral infection and the associated immune response were also assessed. The results of this study suggest that 9 -THC increased viral H1 load, as measured by mRNA levels, through diminished recruitment of CD4 + and CD8 + T lymphocytes. Additionally, there were significant decreases in airway epithelial cell apoptosis and in mucous cell metaplasia associated with 9 -THC treatment and the diminished immune response. (Figure 1 ). On the third day of treatment, mice were instilled intranasally with influenza virus four hours prior to 9 -THC treatment. Mice were killed at 7 and 10 dpi. Day 7 post-infection was previously established as the transition day between neutrophils and lymphocytes infiltrating the airways in response to PR8 infection and the peak day for the detection of immune mediators released by leukocytes in the airways. Day 10 post-infection was previously established as the day that marked the transition from epithelial cell death (7 dpi) to epithelial regeneration and the onset of mucous cell metaplasia (Buchweitz et al., 2007) . Accordingly, two separate experiments were conducted for the measurements of mRNA and BALF at 7 dpi and a third experiment was conducted for routine histopathology and immunohistochemistry at both 7 and 10 dpi. Experimental values obtained for the 9 -THC control group administered 75 mg/kg 9 -THC and intranasally instilled with saline were removed from graphs and tables so as to not draw unwarranted comparisons between this control and PR8 co-treatment groups receiving different dosage levels of 9 -THC. Necropsy, lavage collection, and tissue preparation. Mice were anesthetized by an intraperitoneal injection of 0.1 ml of 12% pentobarbital solution, a midline laparotomy was performed, and mice were exsanguinated by cutting the abdominal aorta. Immediately after death, the trachea was exposed and then cannulated, the heart and lung were excised en bloc. In the first experiment, lung lobes were immersed in TRI reagent and stored at -80 o C until RNA isolation. In the second experiment, 1 ml of sterile saline was instilled through the tracheal cannula and withdrawn to recover bronchoalveolar lavage fluid (BALF). A second saline lavage was performed and combined with the first. In the third experiment, the left and right lung lobes were inflated under constant pressure (30 cm H 2 O) with 10% neutral buffered formalin (Sigma Chemical Co., St. Louis, MO) for 1 h. The tracheal airway was ligated and the inflated lobes were stored in a large volume of the same fixative for at least 24 h until further processing for histopathology.
RNA isolation. Total RNA was isolated from the lung lobes by using the TRI-reagent method 10 curves were generated for each cytokine using the mixed cytokine standard provided with the kit.
The concentration of each cytokine was determined by interpolation from the corresponding standard curve. The range of detection was 20 -5000 pg/ml for each cytokine measured. cytometer. The total number of events taken per each sample was 10,000.
Analysis of BALF
Microdisssection and routine histopathology. The intrapulmonary airways of the fixed left lung lobe from each rodent were microdissected according to a modified version of the technique of Plopper et al., which is fully described in a previous publication (Harkema and Hotchkiss, 1992) . Beginning at the lobar bronchus, airways are split down the long axis of the main axial airway through the twelfth airway generation. Two transverse tissue blocks were excised at the level of the fifth (proximal) and eleventh (distal) airway generation. Transverse tissue blocks were also excised from the middle of the four right lung lobes perpendicular to the largest airway branch entering each lobe. Tissue blocks from the left and right lung lobes were embedded in paraffin, sectioned at a thickness of 5 µm, and then stained with hematoxylin and eosin (H&E)
for light microscopic examination. Other paraffin sections were stained with Alcian Blue (pH 2.5)/Hematoxylin (AB/H) to identify acidic intraepithelial mucosubstances.
Immunocytochemistry. Hydrated paraffin sections (5 µm thick) from formalin-fixed lung tissues were treated with 0.05% proteinase K for 2 min and washed with 1 N HCI for 1 h.
Sections were then treated with 3% H 2 0 2 (in methanol) to block endogenous peroxide and then incubated with a polyclonal antibody to CAS-3 (Abcam, Cambridge, MA) at 20 µg/ml for 1 h.
Immunoreactive CAS-3 was visualized with the Vectastain Elite ABC kit (Vectastain Laboratories Inc., Burlingame, CA) using 3`,3`-diaminobenzidine (DAB) tetrahydrochloride (Sigma Chemical Co., St. Louis, MO) as a chromagen. 
Results
Expression of H1 in mouse lungs challenged with PR8. Hemagglutinin 1 is an influenza virus surface protein that is a specific antigen target for B cell-derived immunoglobulin. H1 mRNA levels in the lungs of mice challenged with influenza in the absence of 9 -THC were significantly elevated at 7 dpi as compared with the saline control (Figure 2) . The H1 mRNA levels in the lungs of mice treated with PR8 and 9 -THC at 25 mg/kg was mildly attenuated as compared with mice challenged with PR8 alone. Viral H1 mRNA levels increased with increasing doses of 9 -THC and were significantly elevated in mice administered 75 mg/kg 9 -THC as compared with PR8 challenged mice in the absence of 9 -THC.
Measurements of injury, immune cell recruitment, and soluble chemical mediators in bronchoalveolar lavage fluid (BALF).
As a measure of alveolar/capillary membrane integrity, total protein in BALF was assayed. There were marked increases in BALF-associated total protein in the influenza group at 7 dpi as compared with saline control, but there were no differences observed in the protein concentration recovered in the BALF from mice treated with any dose of 9 -THC (data not shown).
Consistent with an immune response to viral challenge, the total number of leukocytes in BALF was significantly elevated in mice receiving only influenza at 7 dpi (Table 1 ). There were apparent trends indicating dose-dependent effects of 9 -THC on total cell counts. In spite of this finding, there were marked decreases observed in the number of lymphocytes retrieved in BALF from mice treated with 9 -THC at all dose levels. In addition, treatment of mice with 9 -THC at doses of 25 mg/kg and 50 mg/kg led to decreases in the number of macrophages retrieved in BALF. Flow cytometry was performed to evaluate differences in T lymphocyte subsets in -THC when compared with the influenza group in the absence of 9 -THC.
Secreted inflammatory chemokines and cytokines were measured as an indicator of immune cell function in response to PR8 challenge. Mice challenged with PR8 had significantly increased BALF concentrations of TNF-α, IFN-γ, IL-6, MCP-1, and IL-10 at 7 dpi as compared with the saline control (Table 3 ). In mice treated with 9 -THC, an increase in MCP-1 at a dose of 50 mg/kg was observed.
9
-THC treatment had no effect on BALF associated concentrations of TNF-α, IFN-γ, IL-6, IL-10 or IL-12p70 at any dose when compared with mice treated with PR8 alone.
Descriptive pulmonary histopathology. Exposure of mice to the corn oil vehicle or 9 -THC alone did not result in significant histologic changes within the control mice ( Figure 3A ).
Infection of mice with influenza induced a significant cellular and inflammatory reaction 7 dpi in all lung regions examined. The inflammatory infiltrate was centered upon the bronchioloalveolar duct junction, and extended out into the surrounding alveolar parenchyma. The inflammatory cells were a mix of predominantly lymphocytes and neutrophils, with fewer macrophages and plasma cells. The lymphocytic and neutrophilic population often filled the alveoli, and there was moderate alveolar interstitial infiltration with similar inflammatory cells.
The lymphocytes often formed well-organized perivascular and peribronchiolar aggregates.
Acute epithelial necrosis was present in small numbers of bronchioles, and the remaining epithelial cells were moderately attenuated. At 10 dpi with influenza the inflammation was more severe, and often obscured the alveolar parenchyma ( Figure 3B ). The inflammatory cells 10 dpi JPET #124719
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were primarily lymphocytes, with smaller numbers of neutrophils. The bronchiolar epithelium 10 dpi was moderately hyperplastic and hypertrophied, and there were scattered foci of alveolar bronchiolarization (extension of bronchiolar epithelium into the adjacent alveolar spaces).
Treatment of influenza challenged mice with 9 -THC resulted in no observed decreases in inflammation 7 dpi at each 9 -THC dose. At 10 dpi, treatment with 9 -THC at all dose levels resulted in a mild to moderate decrease in histologically apparent inflammation within the lungs ( Figure 3C ). The inflammation within the mice was not uniformly distributed throughout all lung regions, as found in the control PR8-infected mice. The decreases in inflammation included both decreases in inflammatory cell numbers, as well as extent of distribution within the tissue.
The bronchiolar epithelial changes noted above were still present 10 dpi in influenza infected mice treated with 9 -THC.
Inflammation scores from histopathology. The magnitude and severity of inflammation observed in histological sections of lung isolated from the right and left lobes were independently scored, as described under Methods, and compared between treatment groups at 7 dpi (Figures 4A) and 10 dpi ( Figure 4B ). There was no observed inflammation in the lungs of mice intranasally instilled with saline. In contrast, a marked increase in the inflammation score was noted for lungs in the influenza alone treatment group, representing a moderate to severe inflammatory response. The inflammation scores for sections from mice challenged with PR8
and administered 9 -THC were significantly attenuated at 10 dpi, representing mild to moderate levels of inflammation.
Caspase-3 mRNA expression levels and G5 main axial airway numeric cell densities. There were markedly higher CAS-3 mRNA levels at 7 dpi in total lung homogenates from mice treated JPET #124719
16 with influenza alone as compared with saline control suggesting an increase in apoptotic cell death in response to PR8 infection ( Figure 5A ). There was also an apparent trend toward increasing levels of CAS-3 mRNA with increasing doses of 9 -THC; however, these increases were not statistically significant. In addition, immunohistochemical staining for CAS-3 yielded marked increases in the number of bronchiolar epithelial cells immunoreactive to CAS-3 with influenza treatment alone at 7 dpi (Figures 5B). There was a decrease (p = 0.056) in CAS-3
immunoreactive epithelial cells at 7 dpi with 25 mg/kg 9 -THC treatment ( Figure 5B ). There were no significant differences observed in numeric cell densities for CAS-3 with any of the treatments at 10 dpi ( Figure 5C ).
MUC5AC mRNA expression levels and G5 main axial airway numeric cell densities.
The levels of MUC5AC mRNA were increased in mice challenged with influenza alone ( Figure 6A ).
In mice challenged with PR8 and treated with 25 mg/kg 9 -THC a four-fold increase in MUC5AC mRNA levels was observed when compared with the influenza alone treatment group.
There were also marked increases in the number of epithelial cells staining for alcian blue (acidic mucosubstances) with influenza treatment alone by 10 dpi but not at 7 dpi (Figures 7B and C).
9 -THC treatment did not affect the number of alcian blue-stained epithelial cells observed along the main axial airway at 7 dpi ( Figure 6B ), but did attenuate the number of alcian blue-positive cells observed at 10 dpi in mice receiving 75 mg/kg 9 -THC ( Figure 6C ) as compared with mice challenged with PR8 alone.
Discussion
The objective of the present investigation was to characterize the effects of 9 -THC on the intrapulmonary immune response and associated changes in the morphology of the bronchiolar epithelium following challenge with a nonlethal dose of PR8. In the current study we demonstrated that oral administration of 9 -THC decreased immune competence as evidenced by an increase in influenza viral load, as assessed by H1 mRNA levels, and decreased lymphocytic and monocytic recruitment into the lungs. Oral administration was chosen since it is a relevant route of 9 -THC exposure, as in its synthetic therapeutic form, also known as
Marinol. More importantly,
9
-THC is highly lipophilic requiring a nonaqueous diluent for delivery, which in itself would have the potential for inducing irritation and damage to the airways. In contrast, oral administration of 9 -THC in corn oil, as employed in this study, is well tolerated, albeit, poorly absorbed from the gastrointestinal tract resulting in modest blood concentrations of 9 -THC and its metabolites. Preliminary studies revealed that oral administration of 75 mg/kg 9 -THC for 5 consecutive days led to serum concentrations of 66.2 ng/ml of the parent compound (unpublished observation). These levels correlate well with a previous report by Azorlosa and coworkers in 1992 (Azorlosa et al., 1992) in which human plasma levels ranged from 57 to 268 ng/ml. In the current study, PR8 was administered by intranasal instillation in saline on Day 3, with 9 -THC co-administration surrounding the day of infection. The rationale for this dosing paradigm was to investigate the effects of 9 -THC treatment on the immune response to PR8 during the early stages of infection.
9 -THC-treated mice exhibited higher levels of lung-associated H1 viral mRNA than corn oil-treated mice infected with PR8. In the current study, viral H1 mRNA was measured by real-time PCR, which allowed rapid, sensitive and quantitative analysis of numerous tissue samples while yielding results similar to those typically obtained with more conventional JPET #124719
18 methods (Spackman et al., 2002; Jaspers et al., 2005) . The increased H1 mRNA levels induced by 9 -THC treatment were dose-dependent albeit without an effect on mortality, suggesting that 9 -THC administration impaired immune effectors involved in PR8 clearance. By 10 dpi H1 mRNA levels approached the level of detection (data not shown) in all groups, suggesting that viral clearance had occurred. The timeline of viral clearance is consistent with uncomplicated infections in humans (Hayden et al., 1998) .
The effects of 9 -THC on immune cell function were assessed by the measurement of edema, immune cell recruitment, and cytokine production in response to PR8 challenge.
Epithelial cell death in response to PR8 infection begins as early as 3 dpi and continues through 7 dpi when the epithelium has begun to regenerate (Buchweitz et al., 2007) . 9 -THC had no effect on BALF total protein, suggesting that 9 -THC did not significantly affect the kinetics of inflammatory mediators released by immune cells accruing in alveolar tissue that increase vascular permeability and leakage at the alveolar/capillary interface. Likewise, there was no difference in the total number of leukocytes retrieved in BALF between mice challenged with PR8 in the presence or absence of 9 -THC treatment. In spite of trends toward decreased total leukocytes in BALF with 9 -THC treatment, differential cell counts indicated that 9 -THC treatment decreased, in a dose-related manner, the number of macrophages and lymphocytes in the airways. Dose-dependent modulation of immune cell recruitment to the lungs by 9 -THC during inflammation has been previously reported (Berdyshev et al., 1998) . Lymphocytes infiltrating the airways were comprised of CD4 + and CD8 + T cells. One of the most significant findings in this study was that 9 -THC administration markedly attenuated both CD4 + and CD8 + T cell counts in BALF. Given the marked lymphocytic and monocytic infiltration of the airway submucosa, these data were considered in conjunction with histopathology, which suggests that 9 -THC modulated the immune response to PR8 through an influence on leukocyte migration.
These findings are consistent with cannabinoid effects on lymphocyte and monocyte chemotaxis reported by others (Joseph et al., 2004; Sacerdote et al., 2005; Sacerdote et al., 2000; Stefano et al., 1998) .
As previously reported (Buchweitz et al., 2007) , the immune response to PR8 challenge included a marked increase in IL-6, TNF-α, IFN-γ, MCP-1 and IL-10 by 7 dpi in BALF.
Collectively, no clear profile of activity emerged concerning the effects of 9 -THC on PR8
cytokine or chemokine levels in BALF. This is not altogether surprising as each cytokine and chemokine is regulated in its own unique manner with its own distinct kinetics. In addition, molecular mechanisms by which certain cytokines and chemokines are modulated by cannabinoids are only partially understood. In spite of this, several inflammatory mediators evaluated in this study exhibited dose-dependent modulation in response to 9 -THC treatment.
Specifically, mice treated with 9 -THC at 50 and 75 mg/kg led to increased levels of MCP-1 and IL-6 in BALF, whereas IL-10 concentrations were decreased at these doses. The modulation of these cytokines by cannabinoid treatment is consistent with previous findings in other experimental models (Molina-Holgado et al., 1998; Sacerdote et al., 2005) .
Histopathology revealed that 9 -THC, at all dose levels, attenuated the magnitude of inflammation at 10 dpi. The inflammatory response in the lungs of mice challenged with influenza alone extended beyond the perivascular/peribronchiolar submucosal compartment and into the alveolar parenchyma. With 9 -THC treatment, the inflammatory response was centered on the submucosal compartment. The histopathology supports our finding of decreased numbers of macrophages and lymphocytes observed in BALF from 9 -THC treated mice. Since clearance of influenza virus is critically dependent on both CD4 + and CD8 + T cells, a decrease in their numbers is consistent with the increase in H1 mRNA observed with 9 -THC treatment.
JPET #124719
20
Examination of epithelial cell changes in airways showed that PR8 treatment alone induced CAS-3, a well-known marker for committed activation of apoptosis (Fischer et al., 2003) , as evidenced by mRNA levels and by tissue staining. Since apoptosis can be initiated either directly by the virus in infected host cells (Takizawa et al., 1999; Wurzer et al., 2003) , or by effector cells, specifically cytotoxic T cells and/or NK cells, it is presently unclear which mechanism(s) are predominately responsible for the observed increase in CAS-3. Interestingly, a dose-related decrease in CAS-3 tissue staining, but not mRNA levels was observed with 9 -THC treatment suggesting that 9 -THC may in part interfere with PR8-induced translation of CAS-3 mRNA or at the level of protein synthesis.
Following bronchiolar epithelial shedding at 3 and 7 dpi in response to PR8 infection and concomitant with the cell-mediated immune response, the regenerative airway epithelium undergoes metaplastic changes resulting in increased numbers of mucus goblet cells at 10 dpi (Buchweitz et al., 2007) . MCM is an adaptive response of the epithelium brought about by soluble mediators of inflammation (Jamil et al., 1997; Dabbagh et al., 1999; Shim et al., 2001; Justice et al., 2002; Kawano et al., 2002; Reader et al., 2003 ). An early indicator of increased mucin production, and possibly MCM, is the expression of MUC5AC mRNA that encodes for the goblet cell-derived mucin MUC5AC. Corn oil-treated mice challenged with PR8 exhibited an increase in both the levels of MUC5AC mRNA and alcian blue staining, as shown previously (Buchweitz et al., 2007) . Interestingly, there was a correlative trend in the dose-dependent effects of 9 -THC treatment on MUC5AC mRNA at 7 dpi and alcian blue staining at 10 dpi, suggesting that the effects of 9 -THC on MUC5AC occur at the level of gene transcription. It is unclear whether 9 -THC treatment can directly interfere with the up-regulation of MUC5AC gene transcription or whether the effect is mediated indirectly through the suppression of the inflammatory response that induces MUC5AC transcription.
In conclusion, 9 -THC administration modulated the host-immune response to PR8 as evidenced by an increased viral load and a decreased magnitude of macrophage and lymphocyte (CD4 + and CD8 + ) recruitment. These findings were supported by histopathology and are consistent with similar studies which demonstrated increased susceptibility to the respiratory pathogen, Legionella pneumophila, after 9 -THC administration (Klein et al., 2000) . As in the present study with PR8, Klein and coworkers similarly showed that 9 -THC affected T cell and macrophage function as suggested by altered regulation of T cell-derived cytokines and a suppression of T cell activation to Legionella by attenuation of the expression of co-stimulatory and polarizing molecules on the antigen presenting dendritic cells (Klein et al., 2000; Lu et al., 2006) . Further studies will need to be conducted to determine the effects of 9 -THC on the later stages of the immune response to PR8, as well as to ascertain the role of cannabinoid receptors, CB1 and CB2, on the 9 -THC-mediated effects observed. 
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